• Roche Licenses Promising Huntington’s Therapy IONIS-HTTRx, Begins Extension Study
  • Scientists Control Stem Cells’ Change to Neurons, a Potentially Valuable Tool for Huntington’s
  • Activity and Levels of Enzyme Aco2 May Be Biomarker of Huntington’s Progression, Early Study Reports
  • Taube Philanthropies Donates $750,000 to Buck Institute to Fund Huntington’s Research
  • Rilmenidine Well-Tolerated in HD Patients, but More Studies Needed, Researchers Say
  • Rare Disease Patient Groups Unite to Preserve Orphan Drug Tax Credit in US
  • Hereditary Disease Foundation Gala Raises $900,000 for Huntington’s Research
  • Spanish Study Explains Why Protein Loses Its Ability to Protect Nerve Cells
  • Mitochon Pharmaceuticals Allowed First Patent Securing Development of MP101
  • Canada’s ‘One Extra Push’ Campaign Aims to Raise Awareness of Huntington’s Disease
  • Researchers Identify Mechanism to Prevent Toxic Accumulation of Proteins in Mitochondria
  • Children’s National, NORD Partner to Create Rare Disease ‘Centers of Excellence’